サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494455

欧州のマイクロキャリア：2030年市場予測- 地域別分析- 製品、装置、用途、エンドユーザー別

Europe Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User

出版日
ページ情報
英文 101 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
欧州のマイクロキャリア：2030年市場予測- 地域別分析- 製品、装置、用途、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 101 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のマイクロキャリア市場は、2022年の4億1,719万米ドルから2030年には10億3,552万米ドルに成長すると予想されています。2022年から2030年までのCAGRは12.0%を記録すると推定されています。

マイクロキャリアメーカーの戦略的取り組みと革新的製品が欧州のマイクロキャリア市場を牽引

マイクロキャリア市場で事業を展開する企業は、協業、事業拡大、契約、パートナーシップ、新製品発売などの戦略的開拓に注力しており、これらの戦略的開拓は、売上の向上、地理的範囲の拡大、既存顧客よりも多くの顧客層に対応するための能力強化に役立っています。マイクロキャリア市場における注目すべき開拓をいくつか挙げると、2023年10月、株式会社クラレは再生医療で使用される細胞培養用のPVAハイドロゲルマイクロキャリアを開発しました。国内では2024年1月、海外では米国を皮切りに発売予定。帝人フロンティアは2023年6月、スピーディーかつ大量・高品質な細胞培養を可能にする不織布マイクロキャリアを新発売しました。この不織布マイクロキャリアは、帝人フロンティア独自の繊維加工技術や不織布設計技術、福井大学工学部による繊維関連のバイオメディカルノウハウを融合させたもの。2023年10月、セマリオンはセマサイトマイクロキャリアプラットフォームのアーリーアダプタープログラムを発表しました。セマリオンが開発したSemaCyteは、マイクロチップ製造技術、ナノ磁気、スマート材料を用いて作成された細胞キャリア材料です。これらのアッセイ用マイクロキャリアは平らで、超小型化された磁気的に操縦可能なウェルとして機能し、付着細胞の小さなコロニーを懸濁液に運び、細胞ベースの実験を改善します。2021年1月、サーモフィッシャーサイエンティフィックは、ベルギーを拠点とするグループ・ノヴァセップSASのウイルスベクター製造事業であるHenogen S.A.を買収しました。Henogen社はバイオテクノロジー企業や大手バイオ医薬品企業にワクチンや治療薬の製造サービスを提供しています。この買収により、サーモフィッシャーサイエンティフィックは細胞・遺伝子ワクチンおよび治療薬カテゴリーにおける能力を拡大しました。2020年11月、Singapore-MIT Alliance for Science and Technology（SMART）の研究者らは、大規模細胞生産と細胞拡大のための新規マイクロキャリアを開発しました。このマイクロキャリアを採用することで、企業は従来の方法よりも費用対効果の高い方法で高い収率を得ることができ、同時に細胞回収プロセスに関わる工程数を減らすことができます。SMART社が新たに開発したこの溶解性ゼラチンマイクロキャリアは、骨や軟骨の欠損、移植片対宿主病、すなわち外来の骨髄や細胞に対する拒絶反応など、様々な疾患の治療に用いる細胞増殖に使用できます。したがって、PVAハイドロゲルマイクロキャリア、不織布マイクロキャリア、SemaCyteマイクロキャリアプラットフォームなどの製品を導入し、市場での競争力を維持するために提携やパートナーシップを通じて新規事業を開始することは、マイクロキャリア市場に大きな成長機会を生み出すと思われます。

欧州のマイクロキャリア市場概要

欧州は世界のマイクロキャリア市場で大きなシェアを占めています。同地域の市場成長は、医療分野とインフラが発達していること、ドイツ、英国、フランス、ルーマニア、ポルトガルなどの経済諸国における医療支出が著しく高いことに起因しています。バイオ医薬品の生産性向上や、信頼性の高い成果を伴う継続的な研究のために、細胞培養装置の進歩に対する需要が高まっており、その結果、細胞培養プロセスやシステムの自動化が進んでいます。さらに、受託製造や研究施設は、高度な治療法を求める欧州のヘルスケアセクターの増大し続ける需要に応えるため、巨大な規模で運営されています。ドイツの製薬産業は中小企業で構成されており、世界最大の製薬産業を有する国の中で第4位にランクされています。国際貿易局（ITA）によると、ドイツの医薬品市場は2019年に～625億米ドルを占めました。同国は今後数年間、世界の製薬業界にとって製造・供給面で最も望ましい進出先の1つであり続ける可能性が高いです。業界の成長は、研究開発への投資の増加や特許出願件数の増加といった要因によって牽引されています。パウル・エルリッヒ・インスティトゥート（PEI）の連邦ワクチン・バイオメディカル研究所は、ドイツ市場にリリースされる前のインフルエンザワクチンのバッチ試験を行っています。ドイツは強力な製薬産業であり、研究開発にも力を入れています。NecstGenの報告書によると、2021年にはドイツでCAR改変免疫細胞を評価する29以上の活発な臨床試験が進行中であり、生産の大部分はCAR-T細胞に関するものでした。また、ドイツではこれまでに50以上の遺伝子治療の臨床試験が実施されています。

欧州のマイクロキャリア市場の収益と2030年までの予測（金額）

欧州のマイクロキャリア市場のセグメンテーション

欧州のマイクロキャリア市場は、製品、装置、用途、エンドユーザー、国に区分されます。

製品別に見ると、欧州のマイクロキャリア市場はマイクロキャリアビーズと培地・試薬に二分されます。2022年の欧州のマイクロキャリア市場では、マイクロキャリアビーズセグメントが大きなシェアを占めています。

装置では、欧州のマイクロキャリア市場はバイオリアクター、培養容器、その他に区分されます。バイオリアクターセグメントは2022年に欧州のマイクロキャリア市場で最大のシェアを占めました。

用途別では、欧州のマイクロキャリア市場はバイオ医薬品生産、細胞・遺伝子治療、組織工学・再生医療、その他に区分されます。2022年の欧州のマイクロキャリア市場では、バイオ医薬品生産分野が最大のシェアを占めています。さらに、バイオ医薬品生産セグメントは、治療用タンパク質生産とワクチン生産に分類されます。

エンドユーザーに基づいて、欧州のマイクロキャリア市場は製薬＆バイオテクノロジー企業、契約研究機関＆契約製造機関、学術＆研究機関に区分されます。2022年の欧州のマイクロキャリア市場では、製薬＆バイオテクノロジー企業が最大シェアを占めています。

国別に見ると、欧州のマイクロキャリア市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州のマイクロキャリア市場はドイツが独占。

Teijin Ltd、Bio-Rad Laboratories Inc、denovoMATRIX GmbH、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、Percell Biolytica AB、旭化成Corp、Polysciences Incは、欧州のマイクロキャリア市場で事業展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 欧州のマイクロキャリア市場- 主要産業力学

  • 主な市場促進要因
    • がんと感染症の増加に伴う細胞治療のニーズ
    • 細胞および遺伝子治療製造のアウトソーシングの人気の高まり
    • 再生医療導入の急増
  • 市場抑制要因
    • 生物製剤と細胞ベースの治療薬の高コスト
  • 市場機会
    • マイクロキャリアメーカーによる戦略的取り組みと革新的製品
  • 今後の動向
    • 細胞・遺伝子治療製造サービスの自動化
  • 影響分析

第5章 マイクロキャリア市場- 欧州市場分析

  • マイクロキャリア市場の売上高、2022年～2030年

第6章 欧州のマイクロキャリア市場-2030年までの収益と予測- 製品別

  • マイクロキャリアビーズ
  • 培地および試薬

第7章 欧州のマイクロキャリア市場-2030年までの収益と予測- 装置別

  • バイオリアクター
  • 培養容器
  • その他

第8章 欧州のマイクロキャリア市場-2030年までの収益と予測-用途別

  • バイオ医薬品生産
  • 細胞治療と遺伝子治療
  • 組織工学と再生医療
  • その他

第9章 欧州のマイクロキャリア市場-2030年までの収益と予測‐エンドユーザー別

  • 製薬企業およびバイオテクノロジー企業
  • 受託研究機関および受託製造機関
  • 学術・研究機関

第10章 欧州のマイクロキャリア市場の収益と2030年までの予測：国別分析

    • 欧州
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第11章 マイクロキャリア市場-業界情勢

  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • denovoMATRIX GmbH
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Percell Biolytica AB
  • Asahi Kasei Corp
  • Polysciences Inc

第13章 付録

図表

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. Germany Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. Germany Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. Germany Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. Germany Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. UK Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. UK Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. UK Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. UK Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. France Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. France Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. France Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. France Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Italy Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Italy Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Italy Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Italy Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. Spain Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Spain Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. Spain Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. Spain Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Rest of Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Rest of Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. Recent Organic Growth Strategies in Microcarriers Market
  • Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. Germany: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Italy: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029977

The Europe microcarriers market is expected to grow from US$ 417.19 million in 2022 to US$ 1,035.52 million by 2030. It is estimated to record a CAGR of 12.0% from 2022 to 2030.

Strategic Initiatives and Innovative Products by Microcarrier Manufacturers Drive Europe Microcarriers Market

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned, In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US. In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier's proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan. In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments. In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category. In November 2020, researchers from the Singapore-MIT Alliance for Science and Technology (SMART) developed a novel microcarrier for large-scale cell production and cell expansion. Employing this microcarrier would allow businesses to have higher yields in a more cost-effective way than traditional methods while lowering the number of steps involved in the cell retrieval process. This newly developed dissolvable Gelatin microcarrier from SMART can be used in cell expansion for treating various ailments, including bone and cartilage defects, and graft vs. host disease, i.e., the rejection of foreign bone marrow and cells. Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Europe Microcarriers Market Overview

Europe holds a significant share of the global microcarrier market. The market growth in this region is attributed to the well-developed healthcare sector and infrastructure, and the significantly high healthcare spending in economies such as Germany, the UK, France, Romania, and Portugal. The increasing demand for advancements in cell culture equipment for better biopharmaceutical productivity and ongoing research with reliable outcomes are resulting in automated cell culture processes and systems. In addition, contract manufacturing and research facilities are operating on huge scales to meet the ever-increasing demands of the European healthcare sector for advanced treatment options. The pharmaceutical industry in Germany consists of small and mid-sized companies; it ranks fourth among the countries with the largest pharmaceutical industries in the world. As per the International Trade Administration (ITA), the pharmaceutical market in Germany accounted for ~US$ 62.5 billion in 2019. The country is most likely to remain one of the most desirable destinations for the global pharmaceutical industries over the coming years in terms of manufacturing and supply. The industry's growth is driven by factors such as increasing investments in R&D and the elevating number of patent applications. The Federal Institute for Vaccines and Biomedical Products at Paul-Ehrlich-Institut (PEI) conducts the batch testing of influenza vaccines before their release into the German market. Germany has a strong pharmaceutical industry with a notable R&D focus. As per a NecstGen report, more than 29 active clinical trials evaluating CAR-modified immune cells were underway in Germany in 2021, and the majority of the production involved CAR-T cells. Also, over 50 clinical studies have been conducted in gene therapy in Germany so far.

Europe Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

Europe Microcarriers Market Segmentation

The Europe microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the Europe microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Europe microcarriers market in 2022.

In terms of equipment, the Europe microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Europe microcarriers market in 2022.

Based on application, the Europe microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Europe microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the Europe microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Europe microcarriers market in 2022.

Based on country, the Europe microcarriers market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Europe microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - Europe Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 Europe Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. Europe Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 Europe Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Europe: Microcarriers Market, by Country
      • 10.1.2.1 Germany
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
        • 10.1.2.1.3 Germany: Microcarriers Market, by Product
        • 10.1.2.1.4 Germany: Microcarriers Market, by Equipment
        • 10.1.2.1.5 Germany: Microcarriers Market, by Application
        • 10.1.2.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 Germany: Microcarriers Market, by End User
      • 10.1.2.2 UK
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 UK: Microcarriers Market, by Product
        • 10.1.2.2.4 UK: Microcarriers Market, by Equipment
        • 10.1.2.2.5 UK: Microcarriers Market, by Application
        • 10.1.2.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 UK: Microcarriers Market, by End User
      • 10.1.2.3 France
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 France: Microcarriers Market, by Product
        • 10.1.2.3.4 France: Microcarriers Market, by Equipment
        • 10.1.2.3.5 France: Microcarriers Market, by Application
        • 10.1.2.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 France: Microcarriers Market, by End User
      • 10.1.2.4 Italy
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
        • 10.1.2.4.3 Italy: Microcarriers Market, by Product
        • 10.1.2.4.4 Italy: Microcarriers Market, by Equipment
        • 10.1.2.4.5 Italy: Microcarriers Market, by Application
        • 10.1.2.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.4.6 Italy: Microcarriers Market, by End User
      • 10.1.2.5 Spain
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 Spain: Microcarriers Market, by Product
        • 10.1.2.5.4 Spain: Microcarriers Market, by Equipment
        • 10.1.2.5.5 Spain: Microcarriers Market, by Application
        • 10.1.2.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.5.6 Spain: Microcarriers Market, by End User
      • 10.1.2.6 Rest of Europe
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Europe: Microcarriers Market, by Product
        • 10.1.2.6.4 Rest of Europe: Microcarriers Market, by Equipment
        • 10.1.2.6.5 Rest of Europe: Microcarriers Market, by Application
        • 10.1.2.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.6.6 Rest of Europe: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 denovoMATRIX GmbH
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Sartorius AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Danaher Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Corning Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Eppendorf SE
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Percell Biolytica AB
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Asahi Kasei Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polysciences Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms